Orange Book product · Generic (ANDA)
FULVICIN-U/F
GRISEOFULVIN, MICROSIZE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
GRISEOFULVIN, MICROSIZE
Strength
250MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 060569
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GRISEOFULVIN, MICROSIZE
- 2013GRISEOFULVINGeneric (ANDA)
ANDA 091592 · SANDOZ
- 2012GRISEOFULVINGeneric (ANDA)
ANDA 202482 · SIGMAPHARM LABS LLC
- 2010GRISEOFULVINGeneric (ANDA)
ANDA 065438 · COSETTE PHARMS NC
- 2007GRISEOFULVINGeneric (ANDA)
ANDA 065354 · CIPLA
- 2007GRISEOFULVINGeneric (ANDA)
ANDA 065394 · ACTAVIS MID ATLANTIC
- 2005GRISEOFULVINGeneric (ANDA)
ANDA 065200 · CHARTWELL RX
- 1984GRIFULVIN VGeneric (ANDA)
ANDA 062483 · VALEANT LUXEMBOURG
- —GRIFULVIN VGeneric (ANDA)
ANDA 062279 · VALEANT LUXEMBOURG
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
